Rates of Human papilloma virus (HPV) vaccination among pediatric survivors of cancer and
patients with sickle cell disease are lower than the national average. While recent attention …

Human papillomavirus (HPV) vaccination prevents the development of HPV-associated
malignancies. Adolescent and young adult survivors of childhood cancers and patients with …

PURPOSE: Pediatricians will play a critical role in human papillomavirus (HPV) vaccine
delivery. The objectives of this research were to examine pediatricians' views about key …

METHODS: A national survey among pediatricians and family physicians (FP) was
conducted between October 2013 and January 2014. Using multivariable analysis …

METHODS: We surveyed nationally representative networks of pediatricians and FPs by
Internet or mail from July 2018 to September 2018. Multivariable regression was used to …

Adolescents living in rural areas are less likely to be up to date on the human papillomavirus
(HPV) vaccine, which can prevent cervical cancer. We administered a telephone survey to …

Purpose: We sought to understand clinician-level barriers to providing HPV vaccination to
survivors of childhood and young adult cancers (CYACs). Methods: We conducted 30 …

With discouragingly low vaccination rates for human papillomavirus (HPV), we sought to
improve the HPV vaccine completion rate for adolescents by increasing the consistency and …

The purpose of this study was to identify barriers to and facilitators of human papillomavirus
(HPV) vaccination in children aged 9–17 years across Texas. A literature review informed …

Clinicians' recommendation for the human papillomavirus (HPV) vaccine appears to be an
important driver of parental decisions about vaccination. Our aim was to synthesize the best …